Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-746-5 | CAS number: 2519-30-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
I.F. Gaunt, Madge Farmer, P. Grasso, S.D. Gangolli (1967) was performed on male and female ICI Alderley Park Strain 1 SPF mouse. At concentration of 2000 mg/kg and observed for 14 days. 10 mice/sex were used. The LD50values with 95 % confidence limits were calculated according to Litchfield & Wilcoxon. No toxic signs or deaths were observed during study. Therefore, the LD 50 value of Brilliant Black PN was found to be >2000 mg/kg for mice.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- according to guideline
- Guideline:
- other: as per mentioned below
- Principles of method if other than guideline:
- Oral dosages of compound were administered by oral intubation to the mouse. Animals were observed usually for 14 days during which time the development of toxic signs was followed and time of death recorded.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- mouse
- Strain:
- other: ICI Alderley Park Strain 1 SPF
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: No data available- Age at study initiation: No data available- Weight at study initiation: No data available- Fasting period before study: 18 hr prior to dosing- Housing: No data available- Diet (e.g. ad libitum): No data available- Water (e.g. ad libitum): No data available- Acclimation period: No data availableENVIRONMENTAL CONDITIONS- Temperature (°C): No data available- Humidity (%):No data available- Air changes (per hr): No data available- Photoperiod (hrs dark / hrs light): No data availableIN-LIFE DATES: From: To: No data available
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- No data available
- Doses:
- no data
- No. of animals per sex per dose:
- 10 mice/sex
- Control animals:
- yes
- Details on study design:
- no data available
- Statistics:
- LD50 values with 95 % confidence limits were calculated according to Litchfield & Wllcoxon (1949).
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: with 95 %confidence limits
- Mortality:
- No mortality observed
- Clinical signs:
- other: no toxic signs observed
- Gross pathology:
- No data available
- Other findings:
- Orally, a substantial amount of coloured material was excreted in the faeces.
- Interpretation of results:
- not classified
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- In acute toxicity study by oral route the LD50 value for the Brilliant Black PN was found to be >2000 mg/kg for mice.
- Executive summary:
Acute toxicity test was performed on mice at concentration of 2000 mg/kg and observed for 14 days.10 mice/sex were used. The LD50values with 95 % confidence limits were calculated according to Litchfield & Wilcoxon. No toxic signs or deaths were observed during study.
Therefore, the LD 50 value of Brilliant Black PN was found to be >2000 mg/kg for mice.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Data is from peer reviewed publication
Additional information
Acute oral toxicity:
Several studies for the target chemical Brilliant Black PN and Read across Acid Red 1were reviewed to determine the acute oral toxic nature of the test compound (CAS no 2519-30-4). The studies are summarized as below:
I.F. Gaunt, Madge Farmer, P. Grasso, S.D. Gangolli (1967) was performed on male and female ICI Alderley Park Strain 1 SPF mouse.At concentration of 2000 mg/kg and observed for 14 days.10 mice/sex were used. The LD50values with 95 % confidence limits were calculated according to Litchfield & Wilcoxon. No toxic signs or deaths were observed during study.Therefore, the LD 50 value of Brilliant Black PN was found to be >2000 mg/kg for mice.
Acute toxicity test (I.F. Gaunt, Madge Farmer, P. Grasso, S.D. Gangolli, 1967) was performed on rats at concentration of 5000 mg/kg and observed for 14 days.5 rats/sex were used. The LD50 values with 95 % confidence limits were calculated according to Litchfield & Wilcoxon. No toxic signs or deaths were observed during study. Therefore, the LD50 value for the brilliant black 1 was found to be >5000 mg/kg for rat.
In Long-term Feeding Study on Black PN in Rats, 1972 and Joint FAO/WHO Expert Committee on Food Additives, 2016, acute oral toxicity test was conducted on mouse exposed to Black PN by oral route. LD50 value was found to be >5000 mg/kg in acute oral toxicity of chemical Black PN administered to mouse by oral route.
The acute median lethal dose (LD50) value of Brilliant black 1 in mouse as predicted by Danish Quantitative Structute Activity Relationship Model (2016) is estimated to be19000mg/kg bwadministered to mouse by oral route.
Acute oral toxicity study was conducted (summary of toxicological data of certain food additives – red 2g, 1977) in rats, guinea pigs and rabbits. Rats were administered RED 2G orally through gavage and toxic signs were observed. Histological studies in rats showed extensive renal necrosis. The acute oral LD50 for RED 2G was found to be greater than 5000mg/kg.
Mice were administered RED 2G orally through gavage and toxic signs were observed.
There was gross leptomeningeal vascular engorgement and focal sub-arachnoid haemorrhage observed in the treated mice. The acute oral LD50 for RED 2G was found to be 7350mg/kg in mice.
Guinea Pigs were administered RED 2G orally through gavage and toxic signs were observed.Histological studies in guinea pigs showed extensive renal necrosis. The acute oral LD50 for RED 2G was found to be 4810 (3160-7350) mg/kg in guinea pigs.
Acute oral toxicity study was conducted (summary of toxicological data of certain food additives – red 2g, 1977) in rats, rabbits and guinea-pigs. A dose of 5 g/kg body weight was administered on each of two successive days to a rabbit weighing 3.8 kg and a dose of 25 g/kg body weight was administered on each of two successive days to a rabbit weighing 4.3 kg. No signs of toxicity were observed and their red cells contained no Heinz bodies. Histological studies in guinea pigs showed extensive renal necrosis.
The acute oral LD50 for RED 2G was found to be greater than 5000 mg/kg in rabbits.
Acute Oral study (summary of toxicological data of certain food additives – red 2g, 1977)was carried out on chicken. Chicken were administered RED 2G orally through gavage and toxic signs were observed. The acute oral LD50 for RED 2G was determined to be greater than 10000 mg/kg in chicken.
The above mentioned studies indicate that the substance is not expected to exhibit acute toxicity by oral route as per the CLP criteria.
Justification for selection of acute toxicity – oral endpoint
In acute toxicity study by oral route the LD50 value for the Brilliant Black PN was found to be >2000 mg/kg for mice.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
